Perfil
David S.
Ege currently works at ADC Therapeutics SA, as Chief Technical Officer from 2024.
Dr. Ege also formerly worked at Merck & Co., Inc., as Executive Director-Vaccines & Biologics from 2015 to 2019, Penn Biotech Group Healthcare Consulting, as President, and Seres Therapeutics, Inc., as Chief Technology Officer & Executive VP from 2020 to 2024.
Dr. Ege received his doctorate degree from the University of Pennsylvania and undergraduate degree from Princeton University.
Cargos activos de David Ege
| Empresas | Cargo | Inicio |
|---|---|---|
| ADC THERAPEUTICS SA | Director Técnico/Científico/I+D | 01/10/2024 |
Antiguos cargos conocidos de David Ege.
| Empresas | Cargo | Fin |
|---|---|---|
| SERES THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 31/10/2024 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/06/2019 |
Penn Biotech Group Healthcare Consulting
Penn Biotech Group Healthcare Consulting Miscellaneous Commercial ServicesCommercial Services Operates as a student organization which provides project services on health and biotechnology sector | Presidente | - |
Formación de David Ege.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 6 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Princeton University
Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ADC Therapeutics SA
ADC Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops proprietary antibody drug conjugates for the treatment of both solid and hematological cancers | Health Technology |
Seres Therapeutics, Inc.
Seres Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for diseases related to the human microbiome | Health Technology |
Penn Biotech Group Healthcare Consulting
Penn Biotech Group Healthcare Consulting Miscellaneous Commercial ServicesCommercial Services Operates as a student organization which provides project services on health and biotechnology sector | Commercial Services |
- Bolsa de valores
- Insiders
- David Ege
















